| Oneida A Arosarena, MD | |
|
3509 N Broad St, Philadelphia, PA 19140-4105 | |
| (215) 707-3663 | |
| (215) 707-6417 |
| Full Name | Oneida A Arosarena |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 31 Years |
| Location | 3509 N Broad St, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164475919 | NPI | - | NPPES |
| 1016074130001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | MD428493 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Temple University Hospital | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Temple Faculty Practice Plan Inc | 0345588711 | 1063 |
News Archive
Enrolling in an insurance plan under the Affordable Care Act is only the first step for consumers to be actively engaged in their health care, according to a new analysis from RAND Corporation researchers.
Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.
Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.
Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).
› Verified 2 days ago
| Entity Name | Shriners Hospitals For Children |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1659615706 PECOS PAC ID: 9133031933 Enrollment ID: O20140508000878 |
News Archive
Enrolling in an insurance plan under the Affordable Care Act is only the first step for consumers to be actively engaged in their health care, according to a new analysis from RAND Corporation researchers.
Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.
Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.
Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).
› Verified 2 days ago
| Entity Name | Temple Faculty Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881176949 PECOS PAC ID: 0345588711 Enrollment ID: O20190208002623 |
News Archive
Enrolling in an insurance plan under the Affordable Care Act is only the first step for consumers to be actively engaged in their health care, according to a new analysis from RAND Corporation researchers.
Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.
Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.
Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Oneida A Arosarena, MD 2450 W Hunting Park Ave, Philadelphia, PA 19129-1302 Ph: (215) 707-3633 | Oneida A Arosarena, MD 3509 N Broad St, Philadelphia, PA 19140-4105 Ph: (215) 707-3663 |
News Archive
Enrolling in an insurance plan under the Affordable Care Act is only the first step for consumers to be actively engaged in their health care, according to a new analysis from RAND Corporation researchers.
Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.
Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.
Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).
› Verified 2 days ago
Mark Rizzi, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 34th & Civic Center Blvd, Children's Hospital Of Philadelphia, Philadelphia, PA 19104 Phone: 215-590-3440 Fax: 215-590-3986 | |
Rebecca Claire Chiffer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Chestnut St Fl 6, Philadelphia, PA 19107 Phone: 215-955-6760 | |
Lukas David Dumberger, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-662-2777 Fax: 215-662-4613 | |
Dr. Marc R. Rosen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 925 Chestnut St, 6th Floor, Philadelphia, PA 19107 Phone: 215-955-6760 Fax: 215-923-4532 | |
Dr. Robert T Adelson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 5 Silverstein Building, Philadelphia, PA 19104 Phone: 215-662-2777 | |
Steven Bernard Cannady, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-829-5180 | |
Alexander G Chiu, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, 5 Silverstein Building, Philadelphia, PA 19104 Phone: 215-662-2777 Fax: 215-614-0071 |